Новини фондового ринку
Останні фінансові новини · Оновлено Тра 23, 2026
‘Не зовсім Greggs’: TikTok-креатори тестують «джентрифіковані» пекарні Лондона
‘Not quite Greggs’: TikTok creators put London’s ‘gentrified’ bakeries to the test
The panel's net takeaway is that while these premium-priced, artisanal bakeries benefit from TikTok-driven visibility, their long-term resilience and profitability …
Goldman Sachs підвищує цільову ціну на PVH Corp. (PVH) до $93 з $83
Goldman Sachs Raises its Price Target on PVH Corp. (PVH) to $93 from $83
The panelists had a mixed view on PVH's outlook, with some flagging risks like EMEA softness, reliance on margin expansion, …
Ascendis Pharma A/S (ASND) повідомляє про позитивні дані 52-го тижня з дослідження фази 2 New InsiGHTS
Ascendis Pharma A/S (ASND) Reports Positive Week 52 Data from Phase 2 New InsiGHTS Trial
The panel discusses ASND's Week 52 Phase 2 data showing TransCon hGH's non-inferiority to daily somatropin, with YUVIWEL's EMA approval …
Wolfe Research розпочинає покриття BeOne Medicines AG (ONC) з рейтингом Outperform.
Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating
The panel is neutral on BeOne Medicines (ONC), with concerns about Brukinsa's long-term margins due to generic competition and uncertainty …
Mizuho знижує цільову ціну акцій Autolus Therapeutics plc (AUTL) до $10 з $12
Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12
The panelists debated AUTL's outlook, with some highlighting its strong Q4 results and potential for 2026 inflection, while others raised …
Galapagos NV (GLPG) підписує угоду з Gilead щодо активів Ouro Medicines
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
GLPG's partnership with Gilead on gamgertamig provides a pipeline extension and potential near-to-mid-term catalyst, but the deal's true value lies …
RBC Capital знижує цільову ціну на Bicycle Therapeutics plc (BCYC) до $7 з $11
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
BCYC's one-time revenue from terminated partnerships masks a pivot away from zelenectide due to regulatory feedback, reducing near-term commercialization visibility. …
Найкращі ETF на нафту по $100, які варто купити зараз
The Best ETFs For $100 Oil To Buy Right Now
The panel consensus is that while $105 WTI is driven by geopolitical risks, it may not be sustained due to …
TD Cowen підвищує свою цільову ціну на Marex Group plc (MRX) до $66 з $61
TD Cowen Raises its Price Target on Marex Group plc (MRX) to $66 from $61
Panelists are divided on Marex Group (MRX). Bulls highlight record revenue beats and potential re-rating, while bears question the sustainability …
Золотий ETF із активами на $83,8 млрд та комісією 0,25%, який інвестори продовжують обирати замість GLD
The Gold ETF With $83.8 Billion in Assets and a 0.25% Fee Investors Keep Choosing Over GLD
The panel is divided on IAU's suitability for current portfolios. While some argue it's a useful diversifier and hedge, others …
Буксирні шахрайства стрімко зростають по всій території США — і один випадок у Нью-Йорку показує, наскільки зухвалими стали ці компанії
Towing scams are surging across the U.S. — and one NYC case shows just how brazen these companies have become
The panel discusses the rising issue of predatory towing in NYC, with a focus on its impact on auto insurers. …
«Ми не для того, щоб заробити 5% або 6%»: Воррен Баффетт називає падіння ринку через війну в Ірані «нічим». Що він бачить, чого не бачать інші
‘We aren't in it to make 5% or 6%': Warren Buffett calls Iran war market dip 'nothing.’ What he sees that others don't
The panelists generally agree that Buffett's 'nothing' comment does not signal a bullish stance on equities, with Berkshire Hathaway still …